Covered recipient · General Payments record
THOMAS S ROBINSON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2023
$838.67
- Reported across 45 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $355.70 | 18 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $176.91 | 9 |
| GlaxoSmithKline, LLC. | $100.59 | 5 |
| Acerta Pharma LLC | $37.35 | 2 |
| PFIZER INC. | $20.55 | 1 |
| Novo Nordisk AS | $20.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $15.32 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015794751 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.03 | 04/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015366543 | CMS |
| GlaxoSmithKline, LLC. | $21.26 | 01/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003365961 | CMS |
| GlaxoSmithKline, LLC. | $21.31 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003365949 | CMS |
| GlaxoSmithKline, LLC. | $20.45 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003367325 | CMS |
| GlaxoSmithKline, LLC. | $18.03 | 03/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003365401 | CMS |
| GlaxoSmithKline, LLC. | $19.54 | 04/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003366589 | CMS |
| Lilly USA, LLC | $13.58 | 01/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032208101 | CMS |
| Lilly USA, LLC | $34.58 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032208107 | CMS |
| Lilly USA, LLC | $14.68 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032247379 | CMS |
| Lilly USA, LLC | $23.13 | 03/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032208111 | CMS |
| Lilly USA, LLC | $27.84 | 03/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032208125 | CMS |
| Lilly USA, LLC | $15.23 | 04/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032233815 | CMS |
| Lilly USA, LLC | $28.11 | 04/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032208119 | CMS |
| Lilly USA, LLC | $14.19 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032247385 | CMS |
| Lilly USA, LLC | $5.57 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032413641 | CMS |
| Novo Nordisk Inc | $20.30 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002283869 | CMS |
| PFIZER INC. | $20.55 | 03/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050662935 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.